Richard Bordeleau

President at Fonds Innovexport

Richard Bordeleau

Richard Bordeleau

President at Fonds Innovexport

Overview
Career Highlights

Fonds Innovexport

RelSci Relationships

196

Number of Boards

5

Contact Data
Trying to get in touch with Richard Bordeleau? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Richard Bordeleau likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman-Department of Surgery at Laval University

Relationship likelihood: Strong

Co-Founder at Prevtec Microbia, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Gestion Univalor LP

Relationship likelihood: Strong

President at Medicago USA, Inc.

Relationship likelihood: Strong

Corporate Director at Cari-All Group, Inc.

Relationship likelihood: Strong

Former Advisor to the President at 9342-8530 Québec, Inc.

Relationship likelihood: Strong

President at GeneChem Management, Inc.

Relationship likelihood: Strong

Operating Partner of Pulp, Paper & Tissue at Atlas Holdings LLC

Relationship likelihood: Strong

Former President & Chief Executive Officer at Advitech, Inc.

Relationship likelihood: Strong

Professional at Legend Power Systems, Inc.

Relationship likelihood: Strong

Paths to Richard Bordeleau
Potential Connections via
Relationship Science
You
Richard Bordeleau
President at Fonds Innovexport
Career History
Executive Vice President
Current

Part of Danaher Corp., Biocad Medical, Inc. is a company headquartered in Québec, QC, Canada. The firm develops computer aided software for prosthetics. It was acquired by Nobel Biocare Holding AG, now a subsidiary of Danaher Corp. on 11 Nov 08.

President-Health & Nutrition Division
2001 - 2007

Atrium Innovations, Inc. develops, manufactures and commercializes science based dietary supplements endorsed by health professionals. Its brands include Garden of Life, Seroyal, Trophic, Orthica, Genestra Brands, Minami, Wild Rose, and Pharmax. The company was founded in 1999 and is headquartered in Westmount, Canada.

Senior Vice President-Corporate Development
1994 - 2000

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.

Boards & Committees
Senior Advisor to the Board of Directors
2013 - Current

9342-8530 Québec, Inc. develops and provides immunoassay and molecular diagnostic tests for early cancers. It offers prostate, colorectal, previstage GCC, lung and diagnostic test and other research and development services. The company was founded by Yves Fradet on December 13, 1994 and is headquartered in Quebec, Canada.

Director
Current

Prevtec Microbia, Inc. develops biological products for the prevention of diseases in food-animals. It focuses on the prevention and control of bacterial infections and the improvement of performance in the production of food animals, such as pigs, poultry and cattle. The company was founded in 2003 by John Morris Fairbrother and Eric Nadeau in 2003 and is headquartered in Montreal, Canada.

Member, Investment Committee
Current

MSBi Valorisation, Inc. invests in early-stage technology companies located in Canada. The fund focuses on companies with promising technology and high growth potential. It provides financing for seed stage capital requirements.

Transactions
Details Hidden

Radient Technologies, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard Bordeleau. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard Bordeleau's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard Bordeleau.